VOR
Vor BiopharmaDNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
+
Peers tracked
11
U.S. public peers
Grade Position
Below peers
vs peer average
VOR vs peer average
20/100
VOR vs. peer average (D vs. B)
Grade spread
A 4 · B 1 · C 1 · D 2
Graded peers loaded
Coverage
11 graded
100% of tracked
Peer overview
CTMX is the first available peer comparator.
Loose small-cap biotech comparator for late-stage pipeline dependence and financing sensitivity, though CytomX is not an autoimmune peer.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
VOR
Vor Biopharma
CTMX
CytomX Therapeutics
Grade
D
C
Momentum
22
8
Value
41
53
Sentiment
62
100
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Defensive
Mixed
Grade position vs CTMX
VOR / CTMX
Grade Position
Below peers
VOR vs. peer average (D vs. B)
20/100
Momentum
22
VORValue
41
CTMXSentiment
62
CTMXRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs VOR
CTMX is the first peer returned for this comparison set.